Roche Diagnostics, S.L. secures contract for Blood-Testing Reagents-Reagents and consumables necessary for the genomic detection of hepatitis C (HPC) virus, of the human immunodeficiency virus (HIV) and the hepatitis B (HPB) virus and realization of plasmoteca in blood donors

Spain, May 14 -- Spain based Roche Diagnostics, S.L. has secured contract from Fundacion de Hemoterapia y Hemodonacion de Castilla y Leon for Blood-Testing Reagents-Reagents and consumables necessary for the genomic detection of hepatitis C (HPC) virus, of the human immunodeficiency virus (HIV) and the hepatitis B (HPB) virus and realization of plasmoteca in blood donors. The value of the contract is worth 75306000 EUR.

Published by HT Digital Content Services with permission from Pivotal Sources....